Clinical Trial Update: Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating a vaccine therapy plus sargramostim after chemotherapy in previously untreated aggressive non-Hodgkin's lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Vaccine therapy
• sargramostim (sargramostim)

Snippet

Sponsor: University of Nebraska | Conditions: Lymphoma | Phase 2 | Status: COMPLETED